SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-023055
Filing Date
2019-11-15
Accepted
2019-11-15 16:06:36
Documents
3
Period of Report
2019-11-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20191115_8k.htm 8-K 24107
2 EXHIBIT 99.1 ex_165115.htm EX-99.1 13614
3 ex_165115img001.jpg GRAPHIC 3828
  Complete submission text file 0001437749-19-023055.txt   44533
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 191224559
SIC: 2834 Pharmaceutical Preparations